On ECHEMI
Home > Drugs > Compound pulse induction therapy device

Compound pulse induction therapy device

Ingredients

Product performance: The compound pulse introduction therapeutic instrument adopts microcomputer control, and the output is 2000Hz and 30Hz to 80Hz medium and low frequency sine superposition current, which acts on the treatment acupuncture points through the coupling piece on the treatment head. DYF-A-01; DYF-B-01 type is a simple electric pulse treatment, and DYF-A-02; DYF-B-02 type uses a heatable treatment head while using electric pulse treatment, which has the combined effect of electric pulse and warm effect. This product has the effects of anti-inflammatory and swelling, analgesia and spasm relief, nerve muscle exercise, and improvement of local blood circulation. 1. Output control: The output is divided into 26 levels, which are continuously adjustable from 0 to 25; 0 is no output; 25 is the maximum output; the middle level increases evenly in sequence. The minimum output shall not be greater than 2% of the maximum output. 2. The medium frequency output is a fixed sine wave of 2000Hz±1%, and the low frequency output is a sine wave, with an adjustable frequency of 30Hz~80Hz±1%. 3. Medium frequency output amplitude The medium frequency output amplitude is 20V±30%. The low frequency output amplitude is 20V±30%. 4. Output current: The maximum output current is ≤50mA under a load resistance of 500Ω. 5. Timing function: It is divided into 7 gears: 5min, 15min, 25min, 30min, 35min, 40min, and 100min; the maximum gear error is ±10%. 6. When the output of the therapeutic device is at its maximum, the radiation surface temperature of the treatment head should not exceed 60℃. Structural composition: The therapeutic device consists of a main unit, a treatment head, a power cable, and a coupling plate.

Indication

It is suitable for the treatment of cervical spondylosis, lumbar disc herniation, soft tissue injury, periarthritis of shoulder, and chronic pelvic inflammatory disease. It has an auxiliary therapeutic effect on children's pneumonia and diarrhea.

Packaging Specification

DYF-A-01DYF-A-02DYF-B-01DYF-B-02

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.